Drug Shortages: Sandoz Withdraws From Production of Asthma Emergency Sprays

The withdrawal of the Swiss pharmaceutical company Sandoz from the production of asthma emergency sprays with the active substance salbutamol could lead to bottlenecks. However, the Federal Institute for Medicinal Products and Medical Devices does not see the problem in too much regulation. But Sandoz does.